This list is an analysis based on recent market events. It's not an investment recommendation.
About
BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances. The company was founded in 2007 and is based in Yongin-si, South Korea.
The current price of 199730.KQ is ₩1,295 KRW — it has decreased by -2.63% in the past 24 hours. Watch Bioinfra stock price performance more closely on the chart.
What is Bioinfra stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Bioinfra stocks are traded under the ticker 199730.KQ.
Is Bioinfra stock price growing?▼
199730.KQ stock has fallen by -19.11% compared to the previous week, the month change is a +95.32% rise, over the last year Bioinfra has showed a -72.21% decrease.
Does Bioinfra pay dividends?▼
Yes, 199730.KQ dividends are paid annual. The last dividend per share was 300 . As of today, Dividend Yield (FWD)% is 22.56%.
In which sector is Bioinfra located?▼
Bioinfra operates in the Other sector.
When did Bioinfra complete a stock split?▼
Bioinfra has not had any recent stock splits.
Where is Bioinfra headquartered?▼
Bioinfra is headquartered in Yongin-si, South Korea.